Zobrazeno 1 - 10
of 213
pro vyhledávání: ''
Autor:
Irene Acerbi, Laura J. van't Veer, Jeffrey A. Tice, Yiwey Shieh, Edward Hadeler, Fiona M McAuley, Michelle E. Melisko, Martin Eklund, Nickolas Dreher, Laura J. Esserman, Madeline B. Matthys
Publikováno v:
Breast cancer research and treatment, vol 191, iss 3
Breast Cancer Res Treat
Breast Cancer Res Treat
PurposeThe Breast Cancer Surveillance Consortium (BCSC) model is a widely used risk model that predicts 5- and 10-year risk of developing invasive breast cancer for healthy women aged 35-74years. Women with high BCSC risk may also be at elevated risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c5173bc7fec1248422867614ee493a
https://escholarship.org/uc/item/0pv5w6zf
https://escholarship.org/uc/item/0pv5w6zf
Autor:
Patricia A. Ganz, Ron D. Hays, Reena S. Cecchini, N. Lynn Henry, Andre Rogatko, Sungjin Kim, Michael Luu, Marcio A. Diniz, Greg Yothers
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 39, iss 34
PURPOSE The US National Cancer Institute Moonshot initiative calls for improving analysis and reporting of toxicity to inform treatment tolerability. We used existing clinician-reported adverse event (AE) and patient-reported outcome (PRO) questionna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c434dc713082fe415ce62983d1f89d2
https://escholarship.org/uc/item/8qj1h7zt
https://escholarship.org/uc/item/8qj1h7zt
Autor:
Minh-Phuong Huynh-Le, Roshan Karunamuni, Chun Chieh Fan, Wesley K Thompson, Kenneth Muir, Artitaya Lophatananon, Karen Tye, Alicja Wolk, Hakansson Niclas, Ian G. Mills, Ole A Andreassen, Anders M Dale, Tyler M Seibert, The PRACTICAL Consortium
Publikováno v:
Prostate cancer and prostatic diseases, vol 24, iss 3
65 Background: Clinical variables (age, family history, and genetics) are commonly used for prostate cancer risk stratification. Recently, polygenic hazard scores (PHS46, PHS166) were validated as associated with age at prostate cancer diagnosis. Whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aaeb4b6e65990f9929c479a2bc637ec
https://escholarship.org/uc/item/4255d4t4
https://escholarship.org/uc/item/4255d4t4
Autor:
Leonard Joseph Appleman, Lawrence Fong, Daniel P. Petrylak, Raphaelle Porcu, Ulka N. Vaishampayan, Andrew J. Armstrong, Darren Tayama, Celestia S. Higano, Kobe C. Yuen, Lance C. Pagliaro, Asim Datye, Winston Tan, Edward E. Kadel, Ajjai Alva, Oliver Sartor, Michael J. Morris
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 27, iss 17
Clin Cancer Res
Clin Cancer Res
Purpose:Men with metastatic castration-resistant prostate cancer (mCRPC) have limited treatment options after progressing on hormonal therapy and chemotherapy. Here, we evaluate the safety and efficacy of atezolizumab (anti–PD-L1) + radium-223 dich
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a31d073a659b299e25ab04ad70f292b3
https://escholarship.org/uc/item/5km9c6ps
https://escholarship.org/uc/item/5km9c6ps
Autor:
Anna H. Wu, Veronica Wendy Setiawan, Loic Le Marchand, Daniel O. Stram, Chiu-Chen Tseng, Juan Yang, Jacqueline Porcel, Salma Shariff-Marco, Timothy V. Larson, Pushkar Inamdar, Jun Wu, Jennifer Jain, Scott Fruin, Beate Ritz, Iona Cheng
Publikováno v:
Cancer research, vol 81, iss 16
Cancer Res
Cancer Res
Ultrafine particles (UFP; diameter less than or equal to 100 nm) may reach the brain via systemic circulation or the olfactory tract and have been implicated in the risk of brain tumors. The effects of airport-related UFP on the risk of brain tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b526c3ee884020d2367bc800acb752c
https://escholarship.org/uc/item/8vb3z5c0
https://escholarship.org/uc/item/8vb3z5c0
Autor:
Meghan Sri Karuturi, Tara Sanft, Denise A. Yardley, Angela DeMichele, Sibel Blau, Sara A. Hurvitz, Hope S. Rugo, Amy S. Clark, Amelia Zelnak, Aditya Bardia, Das Purkayastha, Cynthia X. Ma, Lowell L. Hart, Stacy L. Moulder
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 27, iss 15
Purpose: Standard-of-care treatment for metastatic hormone receptor–positive (HR+), HER2-negative (HER2−) breast cancer includes endocrine therapy (ET) combined with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i). Optimal treatment after progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d10c70a51cc377dfe2b31a20be89ec
https://escholarship.org/uc/item/0mj128b0
https://escholarship.org/uc/item/0mj128b0
Autor:
David R. Gandara, Karen Kelly, Mili Arora, Scott D Christensen, Edward J. Kim, Tianhong Li, Thomas J. Semrad, I-Yeh Gong, Jonathan W. Riess
Publikováno v:
Cancer chemotherapy and pharmacology, vol 88, iss 2
Cancer Chemother Pharmacol
Cancer Chemother Pharmacol
PURPOSE: Aurora kinases are overexpressed or amplified in numerous malignancies. This study was designed to determine the safety and tolerability of the Aurora A kinase inhibitor alisertib (MLN8237) when combined with weekly irinotecan. METHODS: In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af97edfacddfcca146b17b9d2c31089
https://escholarship.org/uc/item/8060391g
https://escholarship.org/uc/item/8060391g
Autor:
Mamsau Ngoma, Rebecca DeBoer, Nanzoke Mvungi, Julius Mwaiselage, Elia John Mmbaga, Mwamvita Said, Jerry Ndumbalo, Stephen Meena, Sadiq Siu, Edith A. M. Tarimo, Katherine Van Loon, Rohan Luhar, Msiba Selekwa, Sarah K. Nyagabona, Geoffrey Buckle, Beatrice Mushi
Publikováno v:
The oncologist, vol 26, iss 7
The Oncologist
The Oncologist
Background In response to the increasing burden of cancer in Tanzania, the Ministry of Health, Community Development, Gender, Elderly and Children launched National Cancer Treatment Guidelines (TNCTG) in February 2020. The guidelines aimed to improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85040feae2fa59440920411537817200
https://escholarship.org/uc/item/44h9b90p
https://escholarship.org/uc/item/44h9b90p
Publikováno v:
Clinical lung cancer, vol 22, iss 4
Clin Lung Cancer
Clin Lung Cancer
BackgroundWe analyzed the survival trends for patients with metastatic lung cancer in California.Materials and methodsWe identified patients first diagnosed with primary lung cancer at distant (metastatic) stage in the California Cancer Registry betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57c4582edd67981c836eaef25b3a611d
https://escholarship.org/uc/item/7zw1j7tw
https://escholarship.org/uc/item/7zw1j7tw
Autor:
Elliot Naidus, Lawrence Fong, David Y. Oh, Nathan Standifer, Jerome Bouquet, Timothy Looney, Li Zhang, Hai Yang
Publikováno v:
Cancer immunology, immunotherapy : CII, vol 70, iss 7
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy
Immune checkpoint inhibitors (ICI) are designed to activate exhausted tumor-reactive T cells thereby leading to tumor regression. Durvalumab, an ICI that binds to the programmed death ligand-1 (PD-L1) molecule, is approved as a consolidation therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81755443fe7b823829672ac3b3048c5d
https://escholarship.org/uc/item/53t0g7b0
https://escholarship.org/uc/item/53t0g7b0